Immediate adverse reactions to intravenous immunoglobulin in primary immune deficiencies: a single center experience.

CONCLUSIONS: Use of various intravenous immunoglobulin treatments should be considered with regard to side effect profiles observed. In our cohort, PID patient experienced mostly mild AE; PAD was associated with an increased risk of AE. PMID: 32558411 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/32558411?dopt=Abstract

Source: The Turkish Journal of Pediatrics - June 20, 2020 Category: Pediatrics Authors: Nain E, Kıykım A, Kasap NA, Barış S, Özen A, Aydıner EK Tags: Turk J Pediatr Source Type: research